Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Ankaferd in Epistaxis
NCT06490653Phase 4Not yet recruiting
- Sponsor
- Ankara Atatürk Sanatorium Training and Research Hospital
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Ankaferd Blood Stopper in epistaxis, sponsored by Ankara Atatürk Sanatorium Training and Research Hospital. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
Ankaferd Blood Stopper
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT06490653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06490653.